Whatsapp
Home Our Doctors Dr Nishtha Tripathi
Gynaec Oncology
Dr Nishtha Tripathi

Dr Nishtha Tripathi

Consultant Gynaec-Oncology & Robotic Surgery

Educational Qualifications

MBBS

DGO

DNB (Obstetrics & Gynaecology)

Fellowship in Gynaecological Oncosurgery (RGUHS)

European Board-Certified Gynaecologic Oncologist (ESGO)

Certified PIPAC Surgeon

Experience

10 years of experience


Areas of Expertise

Comprehensive surgical and overall management of gynaecological cancers — ovarian, cervical, endometrial, vulvar and vaginal

Complex Cytoreductive Surgery (CRS) with HIPEC for advanced ovarian cancer and peritoneal surface malignancy

PIPAC (Pressurised Intraperitoneal Aerosol Chemotherapy) for unresectable peritoneal disease

Robotic surgery on the Da Vinci X and SSI Mantra platforms

Advanced laparoscopic gynaecologic oncology

Sentinel lymph node mapping with Indocyanine Green (ICG)

ICG-guided assessment of bowel perfusion in complex pelvic surgery

Fertility-sparing surgery in young patients with early-stage cancer

Hereditary cancer risk counselling — BRCA, Lynch syndrome

Preventive oncology, colposcopy and treatment of precancerous lesions

Multidisciplinary tumour-board planning for complex and recurrent cases


Awards and Recognitions

First Prize, Baptist Clinical Meet 2020 — for clinical research on anthropometry and clinical profiles in Polycystic Ovarian Syndrome (PCOS).

ESGO Certification, European Society of Gynaecological Oncology — successfully cleared the ESGO Examination.

Faculty and oral presentations at the IGCS Annual Global Meeting 2024 (Dublin), AGOICON 2023, AGOICON 2024, and RoboGynIndia 2024.


Membership

European Society of Gynaecological Oncology (ESGO)

International Gynecologic Cancer Society (IGCS)

Association of Gynaecologic Oncologists of India (AGOI)

Association of Gynecologic Robotic Surgeons (AGRS)

Federation of Obstetric & Gynaecological Societies of India (FOGSI)


Publications

Impact of surgical complexity on clinical outcomes in secondary cytoreductive surgery for recurrent ovarian cancer — a tertiary-centre study — International Journal of Gynaecological Cancer.

Bowel anastomosis in cytoreductive surgery and HIPEC — after or before HIPEC? — International Journal of Gynaecological Cancer.

Bi-directional chemotherapy with PIPAC and the intravenous route in advanced primary epithelial ovarian cancer — a new way to travel the old roads — International Journal of Gynaecological Cancer.

Indocyanine green for assessing bowel perfusion in cytoreductive surgery with hyperthermic intraperitoneal chemotherapy — International Journal of Gynaecological Cancer.

Impact of real-time bowel perfusion visualisation with ICG on anastomotic integrity in CRS + HIPEC cases (EV333/#1248) — International Journal of Gynaecological Cancer.

Prospective comparative analysis of complete total parietal peritonectomy versus involved parietal peritonectomy with CRS + HIPEC in advanced ovarian cancer (EV332/#1189) — International Journal of Gynaecological Cancer.

Indocyanine green (ICG) for sentinel lymph node biopsy after neoadjuvant chemotherapy in node-negative patients (EV034/#1242) — International Journal of Gynaecological Cancer.

Association of Kelim Index with Peritoneal Cancer Index and CRS in ovarian cancer patients undergoing interval cytoreductive surgery — from index to impact — International Journal of Gynaecological Cancer.

Kelim Index as a predictor of treatment outcome in ovarian cancer surgery — ASCO Publications.

Fluorescence-guided total robotic parietal peritonectomy, cytoreductive surgery and closed HIPEC — Urology Video Journal.

Atypical presentation of invasive mole in a young female with chemo-resistance — case report and review of literature — Journal of Gynaecology & Women's Health.

Unavoidable caesarean myomectomy in a case of transverse lie with a huge fibroid at incision — SE Asian Journal of Case Reports and Reviews.

Large subserosal fibroid with Mönckeberg's calcification in a postmenopausal woman — iMedPub, Gynaecology & Obstetrics Case Reports.